Limits and uncertainty about telehealth reimbursement have usually been an impediment to adoption. All through the COVID-19 crisis, that load was eased rather, but now the new usual is commencing to acquire shape. What boundaries nonetheless stay to telehealth reimbursement, and how may they be prevail over? To reply that query, host Jonah Comstock and Healthcare Finance Information Taking care of Editor Susan Morse welcome McKinsey & Enterprise companions Oleg Bestsennyy and Gunjan Khanna.
This episode is introduced to you by BlueJeans.
Like what you listen to? Subscribe to the podcast on Apple Podcasts, Spotify or Google Perform!
Chatting factors:
- COVID-19 reimbursement changes and which of them will stick about
- Adoption lessons figured out and how they’ll influence reimbursement coverage
- Holistic tele-treatment and treatment past the video pay a visit to
- Impact of new entrants and innovation on the room
- Is rate-for-company reimbursement an innovation blocker?
- Reimbursement for distinct telehealth modalities
- Time to lead instead than follow for non-public payers?
- The nonetheless-unresolved query of induced utilization
- The increase of price-centered treatment and hybrid treatment models
- Telehealth reimbursement and wellbeing fairness
- How are individuals sensation about telehealth now?
- Ultimate views: the potential of telehealth reimbursement
More about this episode:
Report shows ‘vast improvement’ in condition telehealth reimbursement procedures
COVID-19 may perhaps permanently alter the telehealth landscape, from reimbursement to utilization
Telehealth reimbursement parity spurs insurer issues of overutilization
CMS will reimburse for eleven new telehealth expert services for the duration of the general public wellbeing crisis
Congressional action is desired for telehealth not to return to a rural profit, Seema Verma states
Telehealth: A quarter-trillion-greenback publish-COVID-19 truth? (McKinsey)
COVID-19 Consumer Healthcare Insights: What 2021 may perhaps hold (McKinsey)
How COVID-19 has transformed the way US buyers imagine about healthcare (McKinsey)
About the Author
